Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption - Archive ouverte HAL Access content directly
Poster Communications Year : 2020

Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption

Karine Bilger
  • Function : Author
Jerome Larghero
  • Function : Author
  • PersonId : 887236
Hélène Rouard
  • Function : Author
  • PersonId : 953378
EFS

Dates and versions

hal-03632344 , version 1 (06-04-2022)

Identifiers

Cite

Yingying Wang, Marcelo de Carvalho-Bittencourt, Typhaine Pierre, Mélanie Gauthier, Veronique Decot, et al.. Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption. 46th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting (Virtual), Aug 2020, Virtual Meeting, France. 55 (S1), pp.181-714, 2020, ⟨10.1038/s41409-020-01120-w⟩. ⟨hal-03632344⟩
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More